...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Isoform-selective activation of human constitutive androstane receptor by Ginkgo biloba extract: functional analysis of the SV23, SV24, and SV25 splice variants.
【24h】

Isoform-selective activation of human constitutive androstane receptor by Ginkgo biloba extract: functional analysis of the SV23, SV24, and SV25 splice variants.

机译:银杏叶提取物对人组成型雄甾烷受体的同工型选择性激活:SV23,SV24和SV25剪接变体的功能分析。

获取原文
获取原文并翻译 | 示例

摘要

Naturally occurring splice variants of human constitutive androstane receptor (hCAR) exist, including hCAR-SV23 (insertion of amino acids SPTV), hCAR-SV24 (APYLT), and hCAR-SV25 (SPTV and APYLT). An extract of Ginkgo biloba was reported to activate hCAR-SV24 and the wild type (hCAR-WT). However, it is not known whether it selectively affects hCAR splice variants, how it activates hCAR isoforms, and which chemical is responsible for the effects of the extract. Therefore, we evaluated the impact of G. biloba extract on the functionality of hCAR-SV23, hCAR-SV24, hCAR-SV25, and hCAR-WT and compared it with that of phenobarbital, di-(2-ethylhexyl)phthalate (DEHP), 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime (CITCO), and 1,4-bis-[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) in cell-based reporter gene assays. Among the hCAR splice variants investigated, only hCAR-SV23 was activated by G. biloba extract, and this required cotransfection of a retinoid X receptor alpha (RXRalpha) expression plasmid. The extract activated hCAR-SV23 to a lesser extent than hCAR-WT, but ginkgolide A, ginkgolide B, ginkgolide C, ginkgolide J, and bilobalide were not responsible for the effects of the extract. CITCO activated hCAR-SV23, hCAR-SV24, and hCAR-WT. By comparison, phenobarbital activated hCAR-WT, whereas DEHP activated hCAR-SV23, hCAR-SV24 (with exogenous RXRalpha supplementation), and hCAR-WT. TCPOBOP did not affect the activity of any of the isoforms. G. biloba extract and phenobarbital did not bind or recruit coactivators to the ligand-binding domains of hCAR-WT and hCAR-SV23, whereas positive results were obtained with the controls (CITCO for hCAR-WT and DEHP for hCAR-SV23). In conclusion, G. biloba extract activates hCAR in an isoform-selective manner, and hCAR-SV23, hCAR-SV24, and hCAR-WT have overlapping, but distinct, sets of ligands.
机译:存在人类组成型雄甾烷受体(hCAR)的天然剪接变体,包括hCAR-SV23(插入氨基酸SPTV),hCAR-SV24(APYLT)和hCAR-SV25(SPTV和APYLT)。据报道,银杏叶提取物可激活hCAR-SV24和野生型(hCAR-WT)。但是,尚不清楚它是否选择性地影响hCAR剪接变体,如何激活hCAR同工型以及哪种化学物质负责提取物的作用。因此,我们评估了银杏叶提取物对hCAR-SV23,hCAR-SV24,hCAR-SV25和hCAR-WT的功能的影响,并将其与苯巴比妥,邻苯二甲酸二(2-乙基己基)酯(DEHP)进行了比较。 ,6-(4-氯苯基)咪唑并[2,1-b] [1,3]噻唑-5-甲醛O-(3,4-二氯苄基)肟(CITCO)和1,4-双-[2- (3,5-dichloropyridyloxy)]苯(TCPOBOP)在基于细胞的报告基因分析中。在研究的hCAR剪接变体中,只有hCAR-SV23被银杏叶提取物激活,这需要共转染类视黄醇X受体α(RXRalpha)表达质粒。提取物对hCAR-SV23的活化程度低于hCAR-WT,但银杏内酯A,银杏内酯B,银杏内酯C,银杏内酯J和银杏内酯对提取物的作用不负责任。 CITCO激活了hCAR-SV23,hCAR-SV24和hCAR-WT。相比之下,苯巴比妥激活hCAR-WT,而DEHP激活hCAR-SV23,hCAR-SV24(外源RXRalpha补充)和hCAR-WT。 TCPOBOP不会影响任何同工型的活性。银杏叶提取物和苯巴比妥不与hCAR-WT和hCAR-SV23的配体结合域结合或募集共激活剂,而对照获得了阳性结果(hCAR-WT为CITCO,hCAR-SV23为DEHP)。总之,银杏叶提取物以同工型选择性方式激活hCAR,hCAR-SV23,hCAR-SV24和hCAR-WT具有重叠但不同的配体组。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号